A Systematic Review and Metaanalysis on the Effects of Garlic Preparations on Blood Pressure in Individuals With Hypertension

Abstract

BACKGROUND:

Many patients prefer herbal medications to conventional drugs. Limited trial evidence suggests that garlic preparations reduce high blood pressure (BP).

METHODS:

We searched electronic databases through March 2014 to identify all randomized controlled trials that compared a garlic preparation to placebo in hypertensive patients. Trials were required to report BP values at baseline and after a follow-up of at least 4 weeks.

RESULTS:

Nine double-blind trials with 482 individuals fulfilled our inclusion criteria. Included trials were rather small, and the quality of the majority of included trials was moderate. Follow-up ranged from 8 to 26 weeks. All trials reported office BP measurements. Systolic BP and diastolic BP (SBP and DBP) were more effectively reduced in individuals treated with garlic preparations than in individuals treated with placebo. However, heterogeneity was high (weighted mean difference (WMD) for SBP was -9.1mm Hg; 95% confidence interval (CI), -12.7 to -5.4; P for heterogeneity = 0.0006; and I 2 = 71%; WMD for BP was -3.8mm Hg; 95% CI, -6.7 to -1.0; P for heterogeneity = 0.00001; I 2 = 80%). When analyses were restricted to higher-quality trials using intention-to-treat analysis or to trials with concealed treatment allocation and standardized and blinded BP measurement, effect sizes for SBP but not for DBP were lower and heterogeneity disappeared.

aglio8

CONCLUSIONS:

Although evidence from this review suggests that garlic preparations may lower BP in hypertensive individuals, the evidence is not strong. A well-conducted and powered trial of longer duration is needed to confirm these findings.

© American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

GarlicHBP

Rohner A1, Ried K2, Sobenin IA3, Bucher HC1, Nordmann AJ4.

Author information

  • 1Basel Institute for Clinical Epidemiology and Biostatistics, University of Basel, Switzerland;
  • 2National Institute of Integrative Medicine, Melbourne, Australia;
  • 3Russian Cardiology Research and Production Complex, Moscow, Russia.
  • 4Basel Institute for Clinical Epidemiology and Biostatistics, University of Basel, Switzerland; alain.nordmann@usb.ch.

source: pubmed

Am J Hypertens. 2014 Sep 18. pii: hpu165. [Epub]